Both in Biotechnology
Tarsus Pharmaceuticals vs Adaptive Biotechnologies
Over the past year TARS returned +4.1% and ADPT returned +48.8%; their daily moves had a correlation of 0.17.
TARS +4.1% ADPT +48.8%Growth of $1, one year, split-adjusted
| Metric | TARS | ADPT |
|---|---|---|
| Price | $72.64 | $25.80 |
| Market cap | $3.40B | $4.12B |
| Today | −0.93% | +2.95% |
| 1 month | −2.4% | −13.5% |
| 6 months | +11.7% | +87.2% |
| Year to date | −11.3% | +58.9% |
| 1 year | +5.6% | +48.6% |
| Revenue growth (YoY) | +69.4% | +21.5% |
| Gross margin | 93.0% | 71.8% |
| Net margin | −10.7% | −55.6% |
| P/E (TTM) | — | — |
| Price / sales | 5.6× | 13.4× |
| Net cash | $376.9M | $9.4M |
| Dividend yield | — | — |
| Volatility (60d) | 46.1% | 51.1% |
| Short % of float | 15.3% | 10.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).